Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/19/1999 | EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells |
05/19/1999 | EP0915967A1 Engineering oral tissues |
05/19/1999 | EP0915911A1 Parathyroid hormone analogues for the treatment of osteoporosis |
05/19/1999 | EP0915910A1 Exendin analogues, processes for their preparation and medicaments containing them |
05/19/1999 | EP0915909A1 INSECTICIDAL PROTEIN TOXINS FROM $i(XENORHABDUS) |
05/19/1999 | EP0915904A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
05/19/1999 | EP0915902A1 Transgenic animals expressing artificial epitope-tagged proteins |
05/19/1999 | EP0915709A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
05/19/1999 | EP0915707A1 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
05/19/1999 | EP0915706A1 Screening methods for compounds useful in the regulation of body weight |
05/19/1999 | EP0804456A4 Peptide nucleic acid conjugates |
05/19/1999 | EP0792357A4 Chemical modification of repetitive polymers to enhance water solubility |
05/19/1999 | EP0787179A4 INTERLEUKIN-1-g(b) DEFICIENT TRANSGENIC ANIMALS |
05/19/1999 | EP0654968B1 Anti-microbial composition |
05/19/1999 | EP0605627B1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
05/19/1999 | EP0574466B1 Expression of recombinant proteins in attenuated bacteria |
05/19/1999 | EP0552257B1 A plant protein useful for treating tumors and hiv infection |
05/19/1999 | EP0500921B1 Na-k-atpase inhibiting natriuretic substances |
05/19/1999 | EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS |
05/19/1999 | CN1217027A Parapoxviruses contg. foreign DNA, their prodn. and their use in vacciens |
05/19/1999 | CN1217025A Processed polypeptides with IL-16 activity, process for preparing same and their use |
05/19/1999 | CN1217024A Chemokine alpha 2 |
05/19/1999 | CN1217023A Canine OB protein compositions and method for recombinant prodn. |
05/19/1999 | CN1217022A Therapeutic uses of keratinocyte growth factor |
05/19/1999 | CN1216995A Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
05/19/1999 | CN1216994A Apoptosis inducing molecule II |
05/19/1999 | CN1216918A Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
05/19/1999 | CN1216768A Biologic antibiotic peptide, and method for preparing same |
05/19/1999 | CN1216685A Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
05/18/1999 | US5905187 Antimicrobial peptides and plant disease resistance based thereon |
05/18/1999 | US5905186 Chimeric plant genes based on upstream regulatory elements of helianthinin |
05/18/1999 | US5905146 In general, a novel polypeptide, designated s1-3, is identified and characterized. the mrna for this protein is preferentially overexpressed in senescent human fibroblast cells or fibroblast cells derived from a patient with werner |
05/18/1999 | US5905145 These tumor rejection antigen precursors are referred to as ?tage? tumor rejection antigen precursors. |
05/18/1999 | US5905143 Improving chromatographic purification of protein by further processing of eluant by disrupting hydrophobic interactions between protein-binding material and protein and exposing eluant to ion exchange resin which binds dye |
05/18/1999 | US5905142 Protease resistant PDGF and methods of use |
05/18/1999 | US5905141 Ultra pure hemoglobin solutions and blood substitutes |
05/18/1999 | US5905140 Acylating insulin, insulin analogs, and insulin precursors on free epsilon-amino group of lysine using activated amide with acyl group in polar solvent in presence of base |
05/18/1999 | US5905040 Eukaryotic transfectants express self-assembled empty viral capsids which can be used to vaccinate against the virus or antigenically related species of the virus. |
05/18/1999 | US5905027 Identifying neoplastic brain tissues based on binding affinty of antibodiesto antigens of chloride channels |
05/18/1999 | US5905026 Method of detecting expression of and isolating the protein encoded by the BRCA1 gene |
05/18/1999 | US5905025 Chimeric proteins activating polymerase III transcription, use thereof for detecting and analysing protein-protein interactions and genes coding for said proteins |
05/18/1999 | US5905023 Maspin, a serpin with tumor suppressing activity |
05/18/1999 | US5904920 Regulation of systemic immune responses utilizing cytokines and antigens |
05/18/1999 | CA2187250C Method for producing a soluble protein with bacteria |
05/18/1999 | CA2032191C Expression of the recombinant tumor necrosis factor binding protein i (tbp-i) |
05/18/1999 | CA1340548C Method for producing native hiv gp160 |
05/18/1999 | CA1340547C Novel secretory leader sequences for yeasts |
05/18/1999 | CA1340544C Human tissue factor related dna segments, polypeptides and antibodies |
05/18/1999 | CA1340542C Molecular cloning and characterization of a gene sequence coding for human relaxin |
05/17/1999 | CA2238669A1 A new transcriptional regulatory factor |
05/17/1999 | CA2238666A1 Translational controlling protein for cathepsin b mrna |
05/14/1999 | WO1999023253A1 Stromal cell derived factor-1 (sdf-1) and method of use for diagnostic and prognostic indicator of aids pathogenesis |
05/14/1999 | WO1999023252A1 Cancer gene |
05/14/1999 | WO1999023237A1 Transfecting peptide vector, composition containing same and applications |
05/14/1999 | WO1999023235A1 CORN cDNA ENCODING SOUTHERN LEAF BLIGHT RESISTANCE PROTEIN |
05/14/1999 | WO1999023230A1 Reagents and methods useful for detecting diseases of the breast |
05/14/1999 | WO1999023229A1 A method of inhibiting an immune response to a recombinant vector |
05/14/1999 | WO1999023224A1 A GENE ENCODING A PUTATIVE EFFLUX PROTEIN FOR SOLVENTS/ANTIBIOTICS IN $i(PSEUDOMONAS MENDOCINA) |
05/14/1999 | WO1999023223A1 Induction promoter gene and secretory signal gene usable in $i(schizosaccharomyces pombe), expression vectors having the same, and use thereof |
05/14/1999 | WO1999023222A1 Cysteine noose antibody libraries, means for their production and uses thereof |
05/14/1999 | WO1999023220A1 Suppressor of cytokine signaling |
05/14/1999 | WO1999023219A1 Human slit polypeptide and polynucleotides encoding same |
05/14/1999 | WO1999023218A1 p16-BINDING PROTEINS, GENE THEREOF, AND ANTIBODY THEREAGAINST |
05/14/1999 | WO1999023217A1 A novel gene and uses therefor |
05/14/1999 | WO1999023216A2 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
05/14/1999 | WO1999023214A1 Compositions and methods for enhancing cardiac contractility mediated by myocyte p2 purinoceptors and models thereof |
05/14/1999 | WO1999023213A1 Actin-binding polypeptides and nucleic acids encoding the same |
05/14/1999 | WO1999023211A1 α-AMYLASE MUTANTS |
05/14/1999 | WO1999023201A1 MURD PROTEIN AND GENE OF $i(STREPTOCOCCUS PYOGENES) |
05/14/1999 | WO1999023116A1 ASSAY EMPLOYING CadC FUSION PROTEINS |
05/14/1999 | WO1999023115A1 Glycosylated obesity protein analogs |
05/14/1999 | WO1999023114A1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
05/14/1999 | WO1999023113A2 Rho family antagonists and their use to block inhibition of neurite outgrowth |
05/14/1999 | WO1999023112A1 A FUSION PROTEIN OF hEGF AND HUMAN ANGIOGENIN, AND PROCESS FOR PREPARING THE SAME |
05/14/1999 | WO1999023111A1 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma |
05/14/1999 | WO1999023110A1 Hptlg gene from human hypothalamus |
05/14/1999 | WO1999023107A1 Modification of virus tropism and host range by viral genome shuffling |
05/14/1999 | WO1999023106A1 Caspase-14 polypeptides |
05/14/1999 | WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth |
05/14/1999 | WO1999023065A1 Hemoglobin with chemically introduced disulfide cross-links and preparation thereof |
05/14/1999 | WO1999022773A2 Sequences for targeting metastatic cells |
05/14/1999 | WO1999022765A1 Control of lymphocyte localization by leep-cam activity |
05/14/1999 | WO1999022763A2 Encapsulated immunomodulators useful as vaccine adjuvants |
05/14/1999 | WO1999022762A1 Tolerogenic fragments of natural allergens |
05/14/1999 | WO1999022761A1 Conjugate heat shock protein-binding peptides |
05/14/1999 | WO1999022758A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
05/14/1999 | WO1999022756A1 Cell-permeable protein inhibitors of calpain |
05/14/1999 | WO1999022754A1 Method for administering acylated insulin |
05/14/1999 | WO1999022753A1 Heparin cofactor ii preparations and process for producing the same |
05/14/1999 | WO1999015676B1 A novel generation of cloned horseshoe crab recombinant factor c for detection and removal of endotoxin |
05/14/1999 | WO1999014345A3 Medicament for treating a manifested lyme disease |
05/14/1999 | WO1999012561A3 FRACTURE HEALING USING PTHrP ANALOGS |
05/14/1999 | WO1999011282A9 Compositions and methods for contraception in or sterilization of mammals |
05/14/1999 | WO1999008712A3 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES |
05/14/1999 | WO1999007839A3 Immunoprotective influenza antigen and its use in vaccination |
05/14/1999 | WO1999007739A3 Dna encoding the human synapsin iii gene and uses thereof |
05/14/1999 | WO1999007727A9 Eukaryotic disulfide bond-forming proteins and related molecules and methods |
05/14/1999 | WO1999006068A3 Recombinant dimeric envelope vaccine against flaviviral infection |
05/14/1999 | WO1999005269A8 Transcriptional silencer protein nrf |
05/14/1999 | WO1999004265A8 Cancer associated nucleic acids and polypeptides |